David is a recognised leader in investor and media relations, with more than two decades of experience advising listed and unlisted companies across a wide range of sectors.

As Managing Director of Chapter One Advisors, David brings a hands-on, outcomes-focused approach, underpinned by his deep understanding of capital markets, corporate communications, and stakeholder engagement.

Prior to founding Chapter One, David spent over 13 years as National Director of Investor Relations at PPR, responsible for capital markets strategy for some of Australia’s most high-profile companies. He has served as a director of multiple ASX- listed entities and is also co-founder of investor-focused platforms The Pick and TechInvest. David holds a Bachelor of Commerce from Murdoch University.

Memphasys Limited (ASX: MEM) is an Australian-based reproductive biotechnology company commercialising the Felix™ System, a patented bio separation technology that isolates the most viable sperm cells for human assisted reproduction.

For investor and media enquiries:
David Tasker, Chapter One Advisors
E: dtasker@chapteroneadvisors.com.au
M: +61 433 112 936

Find

Level 1, 34-36 Richmond Road,
Homebush West, NSW 2140
Australia

Call

Privacy Preference Center